Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)

SHE:002107 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	363.42	394.41	344.77	401.1	278.29	326.84
Cash & Short-Term Investments	363.42	394.41	344.77	401.1	278.29	326.84
Cash Growth	-7.52%	14.40%	-14.04%	44.13%	-14.86%	-33.89%
Accounts Receivable	64.09	70.64	71	99.21	146.8	115.59
Other Receivables	2.36	5.42	16.65	19.96	21.23	8.72
Receivables	66.45	76.06	87.65	119.17	168.04	124.31
Inventory	91.22	93.46	107.13	149.09	146.03	165.91
Other Current Assets	7.06	2.84	3.56	3.65	6.84	3.5
Total Current Assets	528.15	566.77	543.12	673	599.21	620.57
Property, Plant & Equipment	305.11	326.45	355.46	382.98	409.78	447.75
Goodwill	32.51	32.51	32.51	32.51	32.51	32.51
Other Intangible Assets	33.47	34.34	35.56	36.84	36.03	54.8
Long-Term Deferred Tax Assets	0.37	0.36	1.03	0.73	1.19	2.76
Other Long-Term Assets	16.74	16.95	18.05	18.65	21.28	2.71
Total Assets	916.35	977.37	985.73	1,145	1,100	1,161

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	31.77	38.75	41.97	54.47	45.28	26.85
Accrued Expenses	5.37	149.07	153.92	170.75	174.06	117.43
Short-Term Debt	-	-	-	-	0.28	-
Current Portion of Leases	0.51	0.92	1.02	0.4	0.73	-
Current Income Taxes Payable	15.25	5.51	3.19	3.13	7.43	7.9
Current Unearned Revenue	3.22	5.44	6.85	5.6	12.43	5.55
Other Current Liabilities	183.55	41.04	35.34	53.64	43.24	46.01
Total Current Liabilities	239.67	240.73	242.29	287.99	283.44	203.74
Long-Term Leases	-	0.23	1.15	-	0.4	-
Long-Term Unearned Revenue	9.62	11.74	14.97	17.93	20.73	23.77
Long-Term Deferred Tax Liabilities	3.5	3.7	4.18	4.59	4.34	3.74
Other Long-Term Liabilities	0.49	0.06	0.21	0.72	1.29	0.58
Total Liabilities	253.29	256.47	262.8	311.23	310.2	231.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	577.21	577.21	577.21	577.21	577.21	577.21
Additional Paid-In Capital	-	-	-	-	-	2.35
Retained Earnings	87.46	146.61	120.16	228.06	169.29	241.16
Total Common Equity	664.67	723.82	697.37	805.27	746.5	820.72
Minority Interest	-1.61	-2.92	25.57	28.21	43.29	108.55
Shareholders' Equity	663.06	720.9	722.93	833.48	789.79	929.26
Total Liabilities & Equity	916.35	977.37	985.73	1,145	1,100	1,161

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	0.51	1.15	2.18	0.4	1.41	-
Net Cash (Debt)	362.91	393.25	342.6	400.7	276.88	326.84
Net Cash Growth	-7.31%	14.79%	-14.50%	44.72%	-15.29%	6.96%
Net Cash Per Share	0.65	0.70	0.56	0.68	0.49	0.56
Filing Date Shares Outstanding	577.21	577.21	577.21	577.21	577.21	577.21
Total Common Shares Outstanding	577.21	577.21	577.21	577.21	577.21	577.21
Working Capital	288.49	326.04	300.83	385.01	315.76	416.82
Book Value Per Share	1.15	1.25	1.21	1.40	1.29	1.42
Tangible Book Value	598.69	656.97	629.3	735.92	677.96	733.41
Tangible Book Value Per Share	1.04	1.14	1.09	1.27	1.17	1.27
Buildings	-	411.09	411.09	411.09	410.52	435.5
Machinery	-	219.04	222.35	223.41	219.51	226.5
Construction In Progress	-	-	-	-	1.58	-

Data Source: S&P Global Market Intelligence Last updated: Oct 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error